{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-039968","form_type":"8-K","ticker":"BEAT","cik":"0001779372","company_name":"HeartBeam, Inc.","filed_at":"2024-09-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:14.493069+00:00","generated_at":"2026-05-31T05:40:33.376104+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"HeartBeam appoints Timothy Cruickshank as CFO; base salary $385K plus equity","bullets":["Timothy Cruickshank appointed CFO effective September 9, 2024.","Annual base salary of $385,000; eligible for 45% incentive bonus and 400,000-share option grant.","Cruickshank was CFO of ImpediMed from Oct 2019 to Mar 2024 with 15+ years medtech experience.","Succeeds Richard Brounstein, who retired in February and remained in advisory capacity."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-039968","json":"https://secwatch.observer/filing/0001628280-24-039968.json","markdown":"https://secwatch.observer/filing/0001628280-24-039968.md","text":"https://secwatch.observer/filing/0001628280-24-039968.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1779372/000162828024039968/0001628280-24-039968-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1779372/000162828024039968/beat-20240909.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T05:40:33.376104+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"cd661b166f","claim":"Timothy Cruickshank was appointed as Chief Financial Officer at HeartBeam, Inc..","evidence_excerpt":"On August 22, 2024, the Board of Directors (the “ Board ”) of HeartBeam, Inc. (the “ Company ”) appointed Timothy Cruickshank as Chief Financial Officer of the Company (the “ Appointment ”) effective as of September 9, 2024.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1779372/000162828024039968/0001628280-24-039968-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}